Molecular Alterations in Hepatocyte Transport Mechanisms in Acquired Cholestatic Liver Disorders

J. O. H. N. LEE; J. A. M. E. S. L. BOYER

doi:10.1055/s-2000-9390

Seminars in Liver Disease, Inhaltsverzeichnis

Semin Liver Dis 2000; Volume 20(Number 03): 373-384
DOI: 10.1055/s-2000-9390

Molecular Alterations in Hepatocyte Transport Mechanisms in Acquired Cholestatic Liver Disorders

JOHN. LEE, JAMES. L. BOYER

From the Department of Internal Medicine and Liver Center, Yale University School of Medicine, New Haven, Connecticut

Abstract

ABSTRACT

Recent advances in the molecular cloning of membrane transport systems that determine bile formation have facilitated studies of the molecular mechanisms of cholestatic liver disease. The present review summarizes what has been learned about the molecular alterations of these membrane transporters in hepatocytes and cholangiocytes in acquired cholestatic liver disorders. Much of this information has been obtained from the study of animal models of cholestasis and from more limited studies in clinical cholestatic liver diseases. Many of these responses may be interpreted as adaptations that serve to diminish cholestatic liver injury.

KEYWORD

cholestasis - membrane transporters - hepatocyte - cholangiocyte - export pumps

Volltext

Referenzen

REFERENCES

1 Trauner M, Meier P J, Boyer J L. Molecular pathogenesis of cholestasis. N Engl J Med . 1998; 339 1217-1227
2 Bezerra J A, Balistreri W F. Intrahepatic cholestasis: Order out of chaos. Gastroenterology . 1999; 117 1496-1498
3 Kartenbeck J, Leuschner U, Mayer R. Absence of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome. Hepatology . 1996; 23 1061-1066
4 Paulusma C C, Kool M, Bosma P J. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology . 1997; 25 1539-1542
5 Wada M, Toh S, Taniguchi K. Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum Mol Genet . 1998; 7 203-207
6 Bull L N, van Eijk M JT, Pawlikowska L. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet . 1998; 18 219-224
7 Strautnieks S S, Kagalwalla A F, Tanner M S. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Am J Hum Genet . 1997; 61 630-633
8 Deleuze J F, Jacquemin E, Dubuisson C. Defect on multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology . 1996; 23 904-908
9 deVree J ML, Jacquemin E, Sturm E. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci USA . 1998; 95 282-287
10 Jansen P L, Strautnieks S S, Jacquemin E. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology . 1999; 117 1370-1379
11 Balistreri W F, Schubert W K. Liver diseases in infancy and childhood. In: Schiff L, Schiff ER, eds Diseases of the liver, 6th ed. Philadelphia: J.B. Lippincott, 1987: 1337-1427
12 Trauner M, Meier P J, Boyer J L. Molecular regulation of hepatocellular transport systems in cholestasis. J Hepatol . 1999; 31 165-178
13 Müller M, Jansen P LM. Molecular aspects of hepatobiliary transport. Am J Physiol . 1997; 35 G1285-G1303
14 Boyer J L, Nathanson M H. Bile formation. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff's diseases of the liver, 8th ed New York: Lippincott-Raven, 1999: 119-146
15 Fitz J G, Scharschmidt B F. Regulation of transmembrane electrical potential gradient in rat hepatocytes in situ. Am J Physiol . 1987; 252 G56-G64
16 Graf J, Henderson R M, Krumpholz B. Cell membrane and transepithelial voltages and resistances in isolated rat hepatocyte couplets. J Membr Biol . 1987; 95 241-254
17 Hagenbuch B, Meier P J. Sinusoidal (basolateral) bile salt uptake systems of hepatocytes. Sem Liver Dis . 1996; 16 129-136
18 Hagenbuch B, Stieger B, Foguet M. Functional expression cloning and characterization of the hepatocyte Na⁺/bile acid cotransport system. Proc Natl Acad Sci USA . 1991; 88 10629-10633
19 Hagenbuch B, Meier P J. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J Clin Invest . 1994; 93 1326-1331
20 Jacquemin E, Hagenbuch B, Stieger B. Expression cloning of a rat liver Na+-independent organic anion transporter. Proc Natl Acad Sci USA . 1994; 91 133-137
21 Kullak-Ublick G A, Hagenbuch B, Stieger B. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology . 1995; 109 1274-1282
22 Abe T, Kakyo M, Sakagami H. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J Biol Chem . 1998; 273 22395-22401
23 Reichel C, Gao B, Van Montfoort J. Localization and function of the organic anion-transporting polypeptide oatp2 in rat liver. Gastroenterology . 1999; 117 688-695
24 Noe B, Hagenbuch B, Stieger B. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proc Natl Acad Sci USA . 1997; 94 10346-10350
25 Abe T, Kakyo M, Tokui T. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem . 1999; 274 17159-17163
26 Kakyo M, Unno M, Tokui T. Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1. Gastroenterology . 1999; 117 770-775
27 Konig J, Cui Y, Nies A T. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol . 2000; 278 G156-G164
28 Hsiang B, Zhu Y, Wang Z. A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl- CoA reductase inhibitor transporters. J Biol Chem . 1999; 274 37161-37168
29 Konig J, Nies A T, Cui Y. Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta . 1999; 1461 377-394
30 Hirohashi T, Suzuki H, Ito K. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats. Mol Pharmacol . 1998; 53 1068-1075
31 Hirohashi T, Suzuki H, Sugiyama Y. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem . 1999; 274 15181-15185
32 Ogawa K, Suzuki H, Hirohashi T. Characterization of inducible nature of MRP3 in rat liver. Am J Physiol Gastrointest Liver Physiol . 2000; 278 G438-G446
33 Smit J JM, Schinkel A H, Elferink R PJO. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell . 1993; 75 451-462
34 Ruetz S, Gros P. Phosphatidylcholine translocase: A physiological role for the mdr2 gene. Cell . 1994; 77 1071-1081
35 Oude Elferink R PJ, Tytgat G NJ, Groen A K. The role of mdr2 P-glycoprotein in hepatobiliary lipid transport. FASEB J . 1997; 11 19-28
36 Paulusma C C, Bosma P J, Zaman G JR. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science . 1996; 271 1126-1128
37 Buechler M, Koenig J, Brom M. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem . 1996; 271 15091-15098
38 Keppler D, Konig J. Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J . 1997; 11 509-516
39 Paulusma C, van Geer M, Evers R. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J . 1999; 338 393-401
40 Ballatori N, Truong A T. Relation between biliary glutathione excretion and bile acid-independent bile flow. Am J Physiol . 1989; 256 G22-G30
41 Gerloff T, Stieger B, Hagenbuch B. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem . 1998; 273 10046-10050
42 Strautnieks S S, Bull L, Knisely A S. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet . 1998; 20 233-238
43 Sippel C J, McCollum M J, Perlmutter D H. Bile acid transport by the rat liver canalicular bile acid transport/ecto-ATPase protein is dependent on ATP but not on its own ecto-ATPase activity. J Biol Chem . 1994; 269 2820-2826
44 Thiebaut F, Tsuruo T, Hamada H. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Nat Acad Sci USA . 1987; 84 7735-7738
45 Kamimoto Y, Gatmaitan Z, Hsu J. The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J Biol Chem . 1989; 264 11693-11698
46 Kool M, de Haas G L, Scheffer G L. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologs of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res . 1997; 57 3537-3547
47 Kool M, van der Linden M, de Haas M. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res . 1999; 59 175-182
48 Borst P, Evers R, Kool M. The multidrug resistance protein family. Biochim Biophys Acta . 1999; 1461 347-357
49 Ujhazy P, Ortiz D F, Misra S. ATP-dependent aminophospholipid translocase activity in rat canalicular membrane vesicles and its relationship to FIC1 [Abstract]. Hepatology . 1999; 30 462A
50 Boyer J L, Soroka C J. Vesicle targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplets. Gastroenterology . 1995; 109 1600-1611
51 Roelofsen H, Soroka C, Dietrich K. Cyclic AMP stimulates sorting of the canalicular organic anion transporter (Mrp2/cMoat) to the apical domain in hepatocyte couplets. J Cell Sci . 1998; 111 1137-1145
52 Che M, Gatmaitan Z, Arias I M. Ectonucleotidases, purine nucleoside transporter, and function of the bile canalicular plasma membrane of the hepatocyte. FASEB J . 1997; 11 101-108
53 Martinez-Anso E, Castillo J E, Diez J. Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver. Hepatology . 1994; 19 1400-1406
54 Cohn J A, Strong T V, Picciotto M R. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology . 1993; 105 1857-1864
55 Strazzabosco M, Joplin R, Zsembery A. Na⁺-dependent and -independent C1^-/HCO^- ₃ exchange mediate cellular HCO^- ₃ transport in cultured human intrahepatic bile duct cells. Hepatology . 1997; 25 976-985
56 Strazzabosco M, Boyer J L. Ion transporters that regulate intracellular pH and secretion in bile duct epthelial cells. In: Sirica AE, Longnecker DS, eds Biliary and pancreatic ductal epithelia: Pathobiology and pathophysiology. New York: Marcel Dekker, 1997: 85-106
57 Welsh M J, Smith A E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell . 1993; 73 1251-1254
58 Colombo C, Battezzati P M, Podda M. Hepatobiliary disease in cystic fibrosis. Semin Liver Dis . 1994; 14 259-269
59 Colombo C, Crosignani A, Battezzati P M. Liver involvement in cystic fibrosis. J Hepatol . 1999; 31 946-954
60 Moseley R H, Wang W, Takeda H. Effect of endotoxin on bile acid transport in rat liver: A potential model for sepsis-associated cholestasis. Am J Physiol . 1996; 271 G137-G146
61 Moseley R H. Sepsis-associated cholestasis. Gastroenterology . 1997; 112 302-306
62 Green R M, Beier D, Gollan J L. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology . 1996; 111 193-198
63 Whiting J F, Green R M, Rosenbluth A B. Tumor necrosis factor-alpha decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis. Hepatology . 1995; 22 1273-1278
64 Bolder U, Huong-Thu T, Schteingart C D. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: Impaired uptake and secretion. Gastroenterology . 1997; 112 214-225
65 Trauner M, Arrese M, Soroka C. The rat canalicular conjugate export pump (mrp 2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology . 1997; 113 255-264
66 Trauner M, Arrese M, Lee H. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest . 1998; 101 2092-2100
67 Vos T A, Guido J, Hooiveld E J. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology . 1998; 28 1637-1644
68 Lee J M, Trauner M, Soroka C J. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology . 2000; 118 163-172
69 Simon F R, Fortune J, Iwahashi M. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol . 1996; 34 G1043-G1052
70 Gartung C, Ananthanarayanan M, Rahman M A. Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology . 1996; 110 199-209
71 Latham P S, Menkes E, Phillips M J. Hyperalimentation-associated jaundice: An example of a serum factor inducing cholestasis in rats. Am J Clin Nutr . 1985; 41 61-65
72 Bossard R, Stieger B, O'Neill B. Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J Clin Invest . 1993; 91 2714-2720
73 Roelofsen H, VanDerVeere C N, Ottenhoff R. Decreased bilirubin transport in the perfused liver of endotoxemic rats. Gastroenterology . 1994; 107 1075-1084
74 Roelofsen H, Schoemaker B, Bakker C. Impaired hepatocanalicular organic anion transport in endotoxemic rats. Am J Physiol . 1995; 32 G427-G434
75 Karpen S J, Sun A, Kudish B. Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter. J Biol Chem . 1996; 271 15211-15221
76 Denson L A, Auld K L, Schiek D S. Interleukin-1β suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J Biol Chem . 2000; 275 8835-8843
77 Makishima M, Okamoto A Y, Repa J J. Identification of a nuclear receptor for bile acids. Science . 1999; 284 1362-1365
78 Parks D J, Blanchard S G, Bledsoe R K. Bile acids: Natural ligands for an orphan nuclear receptor. Science . 1999; 284 1365-1368
79 Gartung C, Trauner M, Schlosser S F. Sodium-independent uptake of bile acids is unaffected by down-regulation of an organic anion transporter (oatp) in rat liver during cholestasis produced by common bile duct ligation (CBDL) [Abstract]. Hepatology . 1996; 24 369A
80 Kubitz R, Wettstein M, Warskulat U. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology . 1999; 116 401-410
81 Rost D, Kartenbeck J, Keppler D. Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin- induced cholestasis. Hepatology . 1999; 29 814-821
82 Green R M, Hoda F, Ward K L. Molecular cloning and characterization of the murine bile salt export pump. Gene . 2000; 241 117-123
83 Reyes H, Simon F R. Intrahepatic cholestasis of pregnancy: An estrogen-related disease. Semin Liver Dis . 1993; 13 289-301
84 Takikawa H, Takamori Y, Sano N. Changes in biliary excretory mechanisms in rats with ethinyl estradiol-induced cholestasis. J Gastroenterol Hepatol . 1998; 13 186-191
85 Stieger B, Fattinger K, Madon J. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology . 2000; 118 422-430
86 Dumont M, Jacquemin E, D'Hont C. Expression of the liver Na+-independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation. J Hepatol . 1997; 27 1051-1056
87 Hirohashi T, Suzuki H, Takikawa H. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J Biol Chem . 2000; 275 2905-2910
88 Paulusma C, Kothe M JC, Bakker C TM. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology . 2000; 31 684-693
89 Buscher H-P, Miltenberger C, Macnelly S. The histoautoradiographic localization of taurocholate in rat liver after bile duct ligation. J Hepatol . 1989; 8 181-191
90 Michalopoulos G K, DeFrances M C. Liver regeneration. Science . 1997; 276 60-66
91 Higgins G H, Anderson R M. Experimental pathology of liver. 1. Restoration of liver of white rat following partial surgical removal. Arch Pathol . 1931; 12 186-202
92 Fukano S, Saitoh Y, Uchida K. Bile acid metabolism in partially hepatectomized rats. Steroids . 1985; 45 209-227
93 Xu H S, Rosenlof L K, Jones R S. Bile secretion and liver regeneration in partially hepatectomized rats. Ann Surg . 1993; 218 176-186
94 Sainz G R, Monte M J, Barbero E R. Bile secretion by the rat liver during synchronized regeneration. Int J Exp Pathol . 1997; 78 109-116
95 Klaassen C D. Comparison of the effects of two-thirds hepatectomy and bile duct ligation on hepatic excretory function. J Pharmacol Exp Ther . 1974; 191 25-31
96 Uesugi T, Bognacki J, Levine W G. Biliary excretion of drugs in the rat during liver regeneration. Biochem Pharmacol . 1976; 25 1187-1193
97 Green R M, Gollan J L, Hagenbuch B. Regulation of hepatocyte bile salt transporters during hepatic regeneration. Am J Physiol . 1997; 36 G621-G627
98 Gerloff T, Geier A, Stieger B. Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. Gastroenterology . 1999; 117 1408-1415
99 Vos T A, Ros J E, Havinga R. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology . 1999; 29 1833-1839
100 Nakatsukasa H, Silverman J A, Gant T W. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication. Hepatology . 1993; 18 1202-1207
101 Shneider B L, Fox V L, Schwarz K B. Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia. Hepatology . 1997; 25 1176-1183
102 Kullak-Ublick G-A, Beuers U, Fahney C. Identification and functional characterization of the promoter region of the human organic anion transporting polypeptide gene. Hepatology . 1997; 26 991-997
103 Konig J, Rost D, Cui Y. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology . 1999; 29 1156-1163
104 Oswald M, Kullak-Ublick G-A, Beuers U. Expression of the hepatocyte canalicular multidrug resistance associated protein 2 (MRP2) in primary biliary cirrhosis [Abstract]. Hepatology . 1998; 28 544A
105 Nozawa S, Miyazaki M, Tou H I. Human MDR1 and MDR3 gene expression in the liver with obstructive jaundice [Abstract]. Gastroenterology . 1997; 112 A1349
106 Dumoulin F L, Reichel C, Sauerbruch T. Semiquantitation of intrahepatic MDR3 mRNA levels by reverse transcription/competitive polymerase chain reaction. J Hepatol . 1997; 26 852-856
107 Kogan D, Ananthanarayanan M, Emre S. The bile salt excretory pump (BSEP/SPGP) is not down-regulated in human cholestasis associated with extrahepatic biliary atresia (EHBA) [Abstract]. Hepatology . 1999; 30 468A
108 Trauner M, Zenz R, Fickert P. Quantification of hepatobiliary transporter expression in liver biopsies from patients with cholestasis [Abstract]. Hepatology . 1999; 30 467A
109 Desmet V J. Vanishing bile duct disorder. In: Boyer JL, Ockner RK, eds Progress in liver diseases. Philadelphia: W.B. Saunders, 1992: 89-122
110 Boyer J L. Vanishing bile duct syndrome-from bench to bedside. In: Alvaro D, Benedetti A, Strazzabosco M, eds. Vanishing bile duct syndrome-pathophysiology and treatment Lancaster: Kluwer Academic Publishers, 1997: 240-245
111 Alvaro D, Gigliozzi A, Piat C. Inhibition of biliary bicarbonate secretion in ethinyl estradiol-induced cholestasis is not associated with impaired activity of the C1^2-<>/HCO3^2-<> exchanger in the rat. J Hepatol . 1997; 26 146-157
112 Lazaridis K N, Pham L, Tietz P. Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. J Clin Invest . 1997; 100 2714-2721
113 Alpini G, Glaser S S, Rodgers R. Functional expression of the apical Na⁺-dependent bile acid transporter in large but not small rat cholangiocytes. Gastroenterology . 1997; 113 1734-1740
114 Lee J M, Azzaroli F, Gigliozzi A. Adaptive regulation of the ileal sodium-dependent bile salt transporter (ISBT), and the multispecific organic anion transporter (MRP2), in kidney and cholangiocytes in chronic cholestasis - alternative pathways for bile salt excretion [Abstract]. Hepatology . 1999; 30 417A
115 Benedetti A, DiSario A, Marucci L. Carrier-mediated transport of conjugated bile acids across the basolateral membrane of biliary epithelial cells. Am J Physiol . 1997; 35 G1416-G1424
116 Prieto J, Qian C, Garcia N. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology . 1993; 105 572-578
117 Medina J F, Martinez-Anso E, Vazquez J J. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology . 1997; 25 12-17
118 Cohn J A, Friedman K J, Noone P G. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med . 1998; 339 653-658
119 Sharer N, Schwarz M, Malone G. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med . 1998; 339 645-652
120 Choudari C P, Lehman G A, Sherman S. Pancreatitis and cystic fibrosis gene mutations. Gastroenterol Clin North Am . 1999; 28 543-549
121 Kool M, van der Linden M, de Haas M. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci USA . 1999; 96 6914-6919
122 Clayton R J, Iber F L, Ruebner B H. Byler disease: Fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child . 1969; 117 112-124
123 Jacquemin E, Cresteil D, Manouvrier S. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet . 1999; 353 210-211
124 Schrenk D, Gant T W, Preisegger K H. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology . 1993; 17 854-860